Corona mutations: This is how quickly manufacturers can adjust the effectiveness of their vaccines

Corona mutations: This is how quickly manufacturers can adjust the effectiveness of their vaccines

Corona vaccines are also currently showing an effect on most virus variants. Can the virus mutate so strongly that the vaccine loses its effectiveness?

In Great Britain and about 100 other countries, the coronavirus variant B.1.1.7 is causing the number of cases to rise exponentially – in South Africa, on the other hand, mutant B.1.351 was developed and in Brazil the variant P1. The vaccination campaign is only gaining momentum in many countries. So many fear that the newly developed vaccines may lose their effectiveness again soon. However, experts give everything clearly.

Do vaccines also work against coronavirus mutations?

What spread to Germany British virus variant B.1.1.7 involvedVaccines appear to protect well. “So far, there are no indications of a significant decrease in the effectiveness of vaccinesWrites Robert Koch Institute (RKI). The situation is different with the South African B.1.351 and the Brazilian variant P1. Both feature a mutation in the spike protein that appears to affect antibody binding. Accordingly, the vaccines no longer work as well. According to a contribution from Deutschland Funk For example, the efficacy of Johnson & Johnson and Novavax vaccines for mutations in South Africa drops to 50 to 60 percent.. Astrazeneca is less effective and can barely prevent even the mildest courses of the disease.

However, there is no reason to be alarmed: because even with the South African alternative, hospital stays with Johnson & Johnson and Novavax could be prevented – So it is very effective against severe courses of Covid-19. There are still no clinical studies on the effectiveness of mRNA vaccines from Moderna and Biontech / Pfizer. However, experts speak in favor of vaccination.

READ  At what age do we start getting old? Science has the answer

How can the effectiveness of existing vaccines against Corona mutations be increased?

The reduced effectiveness in the case of coronavirus mutations does not mean that currently available vaccines will soon become unnecessary. exist Two methods can be used to make these vaccines more effective He can:

  • Booster vaccinationHere, after two regular doses of the vaccine, a third dose is given to increase the antibody level. Other vaccinations have already been successful.
  • “Mix and match”Different vaccines are combined with each other. Clinical studies are already being carried out, for example testing the effectiveness of a mixture of Astrazeneca and Biontech. In fact, this aims to fill gaps in the vaccine supply – but it also likely increases efficacy, as each individual vaccine triggers a slightly different immune response. The results of the studies have not yet been awaited.

Also interesting: A urine test for Covid can predict whether Corona will take a dangerous course – regular approval has already been made.

No more impact with mutations? New vaccines can be developed at this speed

Vaccines are currently also showing efficacy with most of the variants present. However, new vaccines may actually be necessary at some point. But this topic is already being worked on in laboratories today, like deutschlandfunk.de Informed. In principle only information for A mutated spike protein can be incorporated into an existing vaccine formulation This greatly shortens vaccine development and can be completed within six weeks. Meanwhile, the European Medicines Agency (EMA), Germany’s Paul Ehrlich Institute and other European regulatory authorities are studying ways to enable rapid approval. It is important that the manufacturing process be single and that the vaccine quality is guaranteed. In addition, the efficacy of the modified vaccine must be demonstrated in phase 3 clinical studies with a few hundred participants. Something similar is done every year with the flu shot. This way you can A new vaccine was launched on the market in just under six months Become. (fk)

READ  Nicolas Hulot calls for 'change' so that 'chaos don't reign'

Read alsoLong Covid-19 affects 80 percent of Corona patients – five symptoms are the most common.

Life-saving pricks: These high-risk groups should be vaccinated against influenza

The Standing Committee on Vaccination at the Robert Koch Institute (RKI) in Berlin makes recommendations about who should be vaccinated. Do they also belong to the risk group? (As of July 2013) © dpa
The immune system of older people reacts less to the vaccination, but experts recommend the vaccine. In disease, symptoms are weaker. Because there is an increased risk of serious or even fatal complications for people over the age of 60, vaccination is urgently required. © dpa
As with the elderly, there is an increased risk of developing dangerous disease in pregnant women. This is why health experts advise expectant mothers to vaccinate them from the second trimester of pregnancy onwards. Pregnant women who are already suffering from an underlying disease, after consulting a doctor, can get prickling early. © dpa
Adults and children who suffer from a chronic disease such as asthma also belong to high-risk groups. © IFKN, MundiPharma
The flu vaccine is also recommended for people with chronic cardiovascular diseases such as heart failure or high blood pressure. © dpa
Babies cannot be vaccinated against influenza until they are at least six months old. © dpa
Anyone suffering from chronic metabolic diseases such as diabetes (diabetes), from chronic kidney disease, anemia (anemia), from congenital or acquired immune disorders such as immunodeficiency after organ transplantation, from chemotherapy or HIV infection, You should not miss a flu vaccination. © dpa
People with chronic neurological diseases such as multiple sclerosis also belong to high-risk groups. © dpa
Staff in hospitals, nursing homes, doctors’ offices, or employees in facilities with high levels of public traffic are at risk of infecting themselves or others through their work – so vaccination against influenza is in fact mandatory. © dpa
Residents of nursing homes and the elderly are at particular risk. © dpa
Vacationers over the age of 60 or those with chronic illnesses who wish to travel must stab at least two weeks prior to departure. © dpa
People who frequently come into contact with poultry, including wild birds, are also considered an at-risk group. © dpa
People who are allergic to chicken protein are not allowed to be vaccinated. The pollen is grown in chicken eggs. Anyone who currently has a fever should wait for the illness to subside before receiving a vaccination.
Most health insurance companies in Germany voluntarily cover the costs of seasonal influenza vaccinations. People over the age of 60 and those with chronic illnesses usually don’t have to pay anything. © dpa

Leave a Reply

Your email address will not be published. Required fields are marked *